Hospital Pharmacy Europe - Generic medicines,

Click here

Saturday 25 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Generic medicines

Magazine	Sponsored content
News	Video

Thu 4 Apr

Generics and biosimilars in Central and Eastern Europe
Having shown steady recovery from the global economic crisis, the CEE region continues to gain investment from foreign market...

Thu 7 Mar

Actavis launches Montelukast as patents expire in Europe
Actavis, Inc. (NYSE: ACT) has launched Montelukast tablets immediately after patent expiry in Denmark, France, Germany, Ireland,...

Fri 8 Feb

Glenmark launches first UK generic
Glenmark Generics (Europe) Limited (GGEL) has announced the first generic launch of Atovaquone Proguanil in the UK following the...

Mon 19 Mar
2012

Generic positive opinions for EU released
The CHMP adopted a positive opinion on docetaxel and zoledronic acid in its March 2012 meeting

Tue 21 Jun
2011

Europe 'must invest in generics'
Europe must invest in its generics and biosimilar drug market, the EGA annual conference heard

Mon 13 Jun
2011

Heparin: Generic or biosimilar?
Current low-molecular-weight heparins are safe and effective but there is controversy about the status of new products in this...

Mon 13 Jun
2011

Biosimilar monoclonal antibodies: The implications
As many drug companies look to develop biosimilar versions of monoclonal antibodies when their patents expire, it is now vital...

Mon 9 May
2011

Ticagrelor more cost effective over generic clopidogrel
Scottish Medicines Consortium and Danish Ministry of Health and Prevention issue reimbursement decisions

Web design, hosting and programming by ModeZero